[1] |
SHI Yanlei, ZHANG Bing, WANG Yu, XU Zhuoxin, TIAN Min, MENG Min, SA Rina.
Doxorubicin-Induced Cardiotoxicity Related to Regulation of Mitochondrial-Associated Membranes by PDK4
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 863-868.
|
[2] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[3] |
LI Ying, HUANG Lishuang, ZHANG Jingjing, ZHU Yuanchao, SHEN Ji, YANG Jun.
Pharmaceutical Care to a Geriatric Syndrome Patient with Heart Failure Combined with Uremia
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 805-808.
|
[4] |
WANG Yuan, LI Ruoning, GUO Zhanli, ZHANG Lei, LI Jiayuan, DONG Ying, SUN Jianjun.
One Case of Extremely Severe Thrombocytopenia Caused by Tirofiban Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 815-818.
|
[5] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[6] |
GUO Wen, DENG Zhijian, ZHANG Yongheng, GUO Jinhui.
One Case of Atrial Fibrillation Caused by Terazosin Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 580-582.
|
[7] |
WU Shiqi, SU Su, YAN Suying, ZHANG Qingxia.
Bleeding Induced by Rivaroxaban Combined with PK-DDI in Patients with Nonvalvular Atrial Fibrillation and Renal Insufficiency:a Retrospective Cohort Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 415-419.
|
[8] |
LIU Ying, GUO Hongye, YANG Yiheng, JIN Rui.
One Case of Hematological Abnormalities Caused by Lipoic Acid Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 456-459.
|
[9] |
NI Wenqi, ZHU Feng, ZHOU Shuang, CUI Yimin.
Research Progress in Drug-Induced Hypotension
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 475-480.
|
[10] |
LIAO Mengfan, ZHONG Liling, XU Yan, LIU Ying, ZHANG Yexiang, CHEN Qingsong, LIU Xudong.
Adverse Reactions to Antihypertensive and Hypoglycaemic Drugs Based on Spontaneous Presentation Systems
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 286-291.
|
[11] |
YANG Shuzhen, ZHU Chuanming, LI Yan, LIU Tingting, WANG Hongxing, ZHENG Xiaofeng.
Applicability of 99mTc-Ethyl Cysteinate Dimer in the Examination of Ischemic Cerebrovascular Diseases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 313-315.
|
[12] |
YU Li, TAN Xiying.
One Case of Acute Hepatic Injury Caused by Ioversol Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 343-345.
|
[13] |
WANG Songlan, SUN Ying, CHEN Aiqun, JI Liwei.
One Case of Acute Kidney Injury Induced by Evolocumab Injection in a Patient with Chronic Kidney Disease after Renal Transplantation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 221-223.
|
[14] |
HU Yaping, ZHANG Aiwu.
One Case of Acute Drug-Induced Liver Injury Caused by Tingli Jiangxuezhi Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 224-226.
|
[15] |
ZHAO Qiuyue, WEI Hongtao, LI Dandan, YAN An, DI Xuan.
Adverse Reactions of Argatroban in the Treatment of Ischemic Stroke Leading to Gastrointestinal Bleeding
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 88-92.
|